Akio Kinumaki
Akio Kinumaki publishes mostly in Organic Chemistry, Pharmacology and Molecular Biology, on topics such as Microbial Natural Products and Biosynthesis, Synthetic Organic Chemistry Methods and Synthesis of β-Lactam Compounds.
- World rank
- #6,745,141 of 7,710,434 ranked researchers
- Rank in United States
- #1,551,608 of 1,627,098
- Works
- 38
- Citations
- 526
- Citations per work
- 13.8
What does Akio Kinumaki research?
Akio Kinumaki's work is mostly in Chemistry (30%), Biochemistry, Genetics and Molecular Biology (21%), Medicine (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1230.9%
- Physical Sciences1130.0%
- Chemistry1130.0%
- Life Sciences923.6%
- Health Sciences615.5%
- Medicine615.5%
- 1Organic Chemistry30% of their works
- 2Pharmacology16% of their works
- 3Molecular Biology16% of their works
- 4Plant Science3% of their works
- 5Molecular Medicine3% of their works
- 6Cancer Research3% of their works
Research topics
- Microbial Natural Products and Biosynthesis
- Synthetic Organic Chemistry Methods
- Synthesis of β-Lactam Compounds
- Viral Infectious Diseases and Gene Expression in Insects
- Carbohydrate Chemistry and Synthesis
- Synthesis and Biological Activity
- Microbial Metabolic Engineering and Bioproduction
- Antibiotic Resistance in Bacteria
Which keywords describe Akio Kinumaki's research?
The keywords of their largest research topics: Drug Discovery, Natural Products, Enantioselective Synthesis, Olefin Metathesis, Ruthenium Catalysts, Asymmetric Catalysis, Synthesis and Glycosidase Inhibitors.
- Multidrug-Resistant Bacteria
- Genome-Scale Models
- Antibiotic Resistance
- Oligosaccharide Synthesis
- Glycosidase Inhibitors
- Asymmetric Catalysis
- Olefin Metathesis
- Natural Products
- Drug Discovery
- Enantioselective Synthesis
- Ruthenium Catalysts
- Synthesis
- Mammalian Cells
- Recombinant Protein
- Ecteinascidin
- Metabolic Engineering
- Tetrahydroisoquinoline
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Drug Discovery131 topic
- Natural Products131 topic
- Enantioselective Synthesis112 topics
- Olefin Metathesis61 topic
- Ruthenium Catalysts61 topic
- Asymmetric Catalysis51 topic
- Synthesis51 topic
- Glycosidase Inhibitors41 topic
- Mammalian Cells41 topic
- Oligosaccharide Synthesis41 topic
- Recombinant Protein41 topic
- Antibiotic Resistance31 topic
- Ecteinascidin31 topic
- Genome-Scale Models31 topic
- Metabolic Engineering31 topic
- Multidrug-Resistant Bacteria31 topic
- Tetrahydroisoquinoline31 topic
Where does Akio Kinumaki work?
Akio Kinumaki's main affiliation in the publication record is Tanabe Research Laboratories, United States.
How many publications and citations does Akio Kinumaki have?
OpenAlex counts 38 works and 526 citations for Akio Kinumaki, an h-index of 15, ranking #6,745,141 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Akio Kinumaki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.